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In this issue of PLoS Neglected Tropical
Diseases, the Disease Reference Group on
Helminth Infections (DRG4) has put
forward a collection of eight reviews that,
taken together, outline a compelling re-
search and development agenda for the
control and elimination of helminth diseas-
es of humans (http://www.ploscollections.
org/helminths; [1–8]). Emphasis is placed
on six major helminth infections: (i) soil-
transmitted helminthiasis; (ii) schistosomia-
sis; (iii) lymphatic filariasis; (iv) onchocerci-
asis; (v) food-borne trematodiasis; and (vi)
cysticercosis/taeniasis. Selection of these
helminthiases is justified on multiple
grounds. Firstly, as shown in Table 1, more
than half of the world’s population is at risk
of one or several of these helminthiases, and
hundreds of millions of people are currently
infected. Secondly, consequences of the
mainly long-term chronic infection include
suffering, stigmatisation, subtle and gross
morbidity (e.g., anaemia, limb deforma-
tions and blindness), and premature death,
hence causing an intolerable global burden
[9–17]. These features, in turn, exacerbate
poverty [18–20]. Thirdly, there is growing
commitment at all levels—from local
communities to politicians, philanthropic
organisations, and civil society—to control
and eventually eliminate/eradicate the
major human helminthiases.
Figure 1 shows that the six helminthi-
ases are at distinctively different stages of
control and elimination with geographical
idiosyncrasies for some of them [21].
Several helminthiases have been targeted
for elimination (e.g., lymphatic filariasis
and onchocerciasis in the Americas), and
progress made thus far gives hope that this
goal can indeed be achieved by 2015 or
2020 if certain conditions are met [14,21].
For schistosomiasis and soil-transmitted
helminthiasis, discussions are escalating
to shift the focus from control to elimina-
tion [22,23], and in Africa, the African
Programme for Onchocerciasis Control
(APOC) is also moving towards this goal
[24]. The pivotal role of research, coupled
with teaching and training of strong cadres
of researchers from endemic settings as
essential backbones and platforms to
design, implement, and adapt the control
and elimination agenda for major helmin-
thiases as well as other tropical diseases,
cannot be emphasised enough [25–27].
In 2007/2008, the Special Programme
for Research and Training in Tropical
Diseases (TDR), based at and executed by
the World Health Organization (WHO),
and co-sponsored by the United Nations
Children’s Fund (UNICEF), the United
Nations Development Programme (UNDP),
the World Bank and WHO, initiated a
network of disease-specific and thematic
reference groups (DRGs/TRGs). DRG4
was particularly prolific, as witnessed in the
collection of authoritative reviews present-
ed here. This accompanying editorial
summarises the goal, objectives and ex-
pected outcomes of the DRGs/TRGs
global research ‘‘think tank’’. Next, light is
shed on the composition of DRG4, its
mode of operation and its first outputs. It is
then argued that PLoS Neglected Tropical
Diseases is an appropriate outlet for the
studies reviewed and synthesised by DRG4.
Indeed, open access to the identified and
ranked research priorities by all stakehold-
ers is a major asset and is likely to reinforce
the control and elimination agenda of the
major helminthiases.
A Global Research ‘‘Think Tank’’
The idea to create a global network of
DRGs and TRGs as a major international
research ‘‘think tank’’ stems from the fourth
external review of TDR that took place
between February 2005 and May 2006
[28]. The role and operation of this ‘‘think
tank’’ were incorporated into the 10-year
strategic plan of TDR, which is endorsed
by WHO. A key recommendation of the
aforementioned external review was that
TDR should shift its emphasis from
pursuing a model of disease portfolio
(‘‘neglected diseases’’) [29] to infectious
diseases of poverty-related research needs
(‘‘needy populations’’). As a result of this
thinking, the 10-year strategy and underly-
ing business plan of TDR recommended
two strong pillars to position and further
enhance the organisation’s strategic advan-
tages in a rapidly changing global land-
scape of funding, research and develop-
ment: (i) knowledge management that
should lead to the concept of stewardship,
and (ii) capacity building that should foster
empowerment [30].
Conceptualised in 2007/2008, a total of
10 reference groups, six of them with a
disease-specific focus, and the remaining
four with a thematic and cross-cutting
emphasis, were initiated [2] (Table 2; see
also Table S1 in [2]). Each reference
group comprises 10–14 international ex-
perts. Groups are chaired and co-chaired
by renowned scientists, at least one of
whom is based in a developing country. A
competitively selected young career re-
search fellow is offered the opportunity to
be part of the group, primarily pursuing
research within the realm of the group, but
also charged with some limited operation-
al and managerial tasks to ascertain
smooth operation of the groups. The
reference groups are hosted by WHO
country offices in Africa, Asia, and Latin
America.
As per TDR’s latest 10-year strategy and
vision, the global network of DRGs and
TRGs operate within the guiding principles
of knowledge management and capacity
building, thus emphasising stewardship and
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empowerment. The specific objectives are
to systematically review, debate, and syn-
thesise available information and to define
and rate research priorities. This is facili-
tated by regular meetings (it was initially
planned that the groups would meet once a
year for 3–5 days), usually in the hosting
country of a specific group. Broad stake-
holder consultation, usually at the outset of
the meetings, was adopted as an integral
part of the modus operandi of the groups.
The Disease Reference Group
on Helminth Infections (DRG4)
DRG4 initially comprised 14 individu-
als. The group is chaired by Sara Lustig-
man at the Lindsley F. Kimball Research
Institute, New York Blood Center in New
York, United States of America. Boakye
A. Boatin serves as the co-chair, currently
affiliated with two institutions, the Institute
of Parasitology, McGill University (Mon-
treal, Canada), and the Noguchi Memorial
Institute of Medical Research, University
of Ghana (Legon, Ghana). The career
research fellow is based at the Council for
Figure 1. Stages of control/elimination of the six helminthiases emphasised by DRG4. The schematic representation shows the different
stages of a control programme (from morbidity to transmission control), including the extreme ends (i.e., no control, extent of the problem yet to be
determined on the far left; and elimination on the far right). Colour codes of horizontal lines: black, global; blue, Latin America and Caribbean; red,
sub-Saharan Africa; brown, Middle East and North Africa; green, Asia. Dashed lines indicate that, in some counties within a sub-region (or globally),
the control/elimination is less or more advanced than in the sub-region (or globally) overall.
doi:10.1371/journal.pntd.0001646.g001
Table 2. Global Network of Disease-Specific Reference Groups (DRGs) and Thematic Reference Groups (TRGs).
DRG and TRG Disease(s) or Thematic Focus Hosting Institution(s) and Country(ies)
DRG1 Malaria WHO Regional Office for Africa (AFRO), Republic of the Congo
DRG2 Tuberculosis, leprosy, and Buruli ulcer WHO Country Office for the Philippines
DRG3 Chagas disease, human African trypanosomiasis, and leishmaniasis WHO Country Offices for Sudan and Brazil
DRG4 Helminthiases African Programme for Onchocerciasis Control (APOC),
Burkina Faso
DRG5 Dengue and emerging viral diseases WHO Country Office for Cuba
DRG6 Zoonosis and marginalised infectious diseases WHO Regional Office for Easter and Mediterranean (EMRO), in
collaboration with WHO Country Office for Egypt
TRG1 Social science and gender WHO Country Office for Ghana
TRG2 Innovation and biotechnology platforms WHO Country Office for Thailand
TRG3 Implementation and health systems research WHO Country Office for Nigeria
TRG4 Environment, agriculture and human health WHO Country Office for the People’s Republic of China
In 2007/2008, the Special Programme for Research and Training in Tropical Diseases (TDR) set up a global network of DRGs and TRGs as an independent ‘‘think tank’’ of
international experts. The groups met regularly to review, debate, and synthesise existing information, including stakeholder consultation. The ultimate aim was to establish
and strengthen an evidence base on infectious diseases of poverty and cross-cutting themes, including identifying knowledge gaps and current research priorities.
doi:10.1371/journal.pntd.0001646.t002
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Scientific and Industrial Research, Water
Research Institute, in Ghana. The writing
core team includes Sara Lustigman, Boa-
kye A. Boatin, Marı´a-Gloria Basa´n˜ez
(United Kingdom), and Roger K. Prichard
(Canada). The geographical representa-
tion of the remaining nine members
reveals two from Africa (Coˆte d’Ivoire
and Ghana), two from Asia (Thailand and
People’s Republic of China), two from
Latin America (Brazil and Peru), two from
Oceania (Australia), and one from the
Middle East (Egypt).
At the outset, the group identified
research gaps and pursued a multi-criteria
assessment, including stakeholder consul-
tation, and Delphi approach that ultimate-
ly resulted in a consolidated list of the 10
top research priorities. This forms the
‘‘white paper’’ of the DRG4, i.e., recog-
nising and pursuing these priorities in
order to achieve control and elimination
of major human helminthiases. This
‘‘white paper’’ is co-authored by the entire
group [2]. Next, an in-depth analysis
outlines the problem of human helminthi-
ases, emphasising the omnipresence of
single and multiple species parasitic worm
infections and their intricate relationship
with poverty [1]. Visualising this collection
as house, the reviews highlighting the
problem of human helminthiases, and
issues towards control and elimination,
are like the foundation upon which the
building is erected (Figure 2). Key proposed
responses for the helminthiases control and
elimination agenda are reviewed in four
separate pieces that are the main building
blocks of the house. These include basic
research and enabling technologies [3],
new and improved intervention tools and
strategies, such as drugs, vaccines, and for
some of the helminthiases also vector
control [6], diagnostics [4], and mathemat-
ical modelling to inform policy and rein-
force research [5]. Understanding social-
ecological contexts, environmental deter-
minants, and health systems forms the first
layer of the roof [7]. Health research and
capacity building in developing country
settings is of such pivotal importance that it
is layered on top of a well-built house, and
hence reinforces the agenda [8].
It is, perhaps, interesting to note that
key research and development (R&D)
issues have already been discussed in
connection with a malaria eradication
research agenda (malERA). Facilitated by
a 2-year broadly integrative and iterative
process led by a core team, and assisted by
various experts groups and involving more
than 250 scientists, programme managers
and decision-makers from the public and
private sectors in a series of consultations,
the malERA went live in a special issue of
PLoS Medicine in early 2011 [27]. Similar
R&D issues were identified in parallel by
the malERA and the series presenting the
research agenda for helminth infections of
humans. Once the collection of malERA
papers came out, they served as an
inspiration to also publish the comprehen-
sive R&D agenda pertaining to human
helminthiases in a collection of reviews,
and PLoS Neglected Tropical Diseases was
deemed a suitable outlet. Both agendas
feature basic science and enabling tech-
nologies [3,31], diagnoses and diagnostics
[4,32], modelling [5,33], and health sys-
tems issues [7,34]. While the helminthiases
agenda has a single chapter on interven-
tions (due to the fact that, for instance,
interventions such as anti-helminth vac-
cines are in earlier stages of development
for use in humans [35]), in the malERA,
there are three separate contributions for
interventions: drugs, vaccines, and vector
control [36–38]. This difference further
emphasises the neglect in R&D funding
for novel and repositioned intervention
tools to control human helminth infections
as opposed to malaria [39]. Additionally,
the malERA views the issues of monitor-
ing, evaluation, and surveillance (the latter
further developed as ‘‘surveillance as an
intervention’’) of such great importance
that space is given for a full contribution
[40]. Together with a piece on cross-
cutting issues for eradication, lessons
learned from the first malaria eradication
era in the 1950s and 1960s, and the
aforementioned umbrella [27], the mal-
ERA certainly is a key resource for
developing control and elimination/erad-
ication agendas for human infectious
diseases, including human helminthiases.
However, the research agenda for helmin-
thiases is unique in its contribution of a
separate article fully considering the issues
of capacity building for health research
and disease control in endemic countries
Figure 2. A research agenda for the control and elimination of major helminthiasis put forth by DRG4. This figure synthesises the key
written outputs from DRG4, visualising this collection of eight reviews as a house (strong foundation, major building blocks and a two-layered roof).
doi:10.1371/journal.pntd.0001646.g002
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[8], which is absent in the malERA
collection. Both collections therefore
should be considered together as prime
examples of major outputs produced by
think tanks, driven by core writing teams
and stakeholder engagement in the cur-
rent global efforts to help control and
eliminate poverty-related diseases [21].
Going Live in PLoS Neglected
Tropical Diseases
In terms of writing, the various DRGs
and TRGs were charged to produce
annual reports. Additionally, the groups
were requested to have these reports
further developed into stand-alone com-
prehensive Technical Report Series, to be
published by the WHO. Unfortunately, at
the time these reports were submitted to
TDR, the organisation sailed through
troubled waters, delaying internal process-
ing and external peer review. Yet, there is
new traction and it is hoped that the
planned WHO Technical Report Series
will soon come to bear. In the meantime,
the Disease Reference Group on Zoonoses
and Marginalized Infectious Diseases
(DRG6) disseminated a most useful over-
view article through the open-access
journal Parasites & Vectors [41].
The efforts made by DRG4 to produce
no less than eight major reviews are
commended and PLoS Neglected Tropical
Diseases clearly is an appropriate outlet for
this collection of articles. To wit, within 2–
3 years after the launch of PLoS Neglected
Tropical Diseases in late 2007, this open-
access vehicle established itself as the
leading peer-reviewed journal in tropical
medicine. Two seminal papers published
in 2005 and 2006 provided an initial list of
15 neglected tropical diseases, the majority
of which were due to helminth infections
[42,43]. Indeed, all of the six helminthia-
ses emphasised by DRG4 were part of the
initial scope of PLoS Neglected Tropical
Diseases. Meanwhile, the scope of the
journal has broadened considerably [44],
and now also includes a growing number
of bacterial, protozoal, viral, and ectopar-
asitic infections, but helminthiases still
figure prominently. Indeed, as shown in
Table 3, more than 20% of the over 1,300
original articles, reviews, and front-matter
pieces focus on helminth infections.
Lessons Learned and Next Steps
Sixty-five years after the landmark
publication of Norman R. Stool entitled
‘‘This Wormy World’’ [45], it is clear that
helminthiases are still widespread and
continue to pose a huge public health
problem. Indeed, a situation analysis
reveals that more than half of the word’s
population is at risk of helminth infection,
more than a billion people are currently
infected, often with multiple species, and
helminthiases are rife where poverty and
malnutrition prevail, in the face of lack
of access to basic infrastructure (e.g., clean
water and sanitation) and hygiene
[17,20,46]. These facts form the founda-
tion of the current article collection [1,2].
Responses on how to control and eventu-
ally eliminate human helminthiases re-
quire ethically, technically and scientifical-
ly sound research to improve current
tools and strategies, as summarised in the
Table 3. Number and Percentage of Helminth-Related Articles Published in PLoS
Neglected Tropical Diseases.
Search Strategy No. (%) of Hits
PLoS Neglected Tropical Diseases 1335 (100)
Protozoan infections 294 (22.0)
Helminth infections 277 (20.7)
Viral infections 212 (15.9)
Bacterial infections 185 (13.9)
Fungal infections 11 (0.8)
Ectoparasitic infections 0
Helminths (parasitic worms) 481 (36.0)
Trematodes 103 (7.7)
Nematodes 101 (7.6)
Cestodes 26 (1.9)
Helminthic diseases 260 (19.5)
Schistosomiasis 138 (10.3)
Lymphatic filariasis 57 (4.3)
Soil-transmitted helminthiasis 36 (2.7)
Onchocerciasis 34 (2.5)
Echinococcosis 25 (1.9)
Cysticercosis 23 (1.7)
Taeniasis 20 (1.5)
Toxocariasis 7 (0.5)
Loiasis 6 (0.4)
Food-borne trematodiasis 1 (0.1)
Dracunculiasis 0
Important helminth species
Schistosoma mansoni 80 (6.0)
Hookworm 49 (3.7)
Schistosoma japonicum 39 (2.9)
Trichuris trichiura 32 (2.4)
Ascaris lumbricoides 31 (2.3)
Brugia malayi 21 (1.6)
Strongyloides stercoralis 17 (1.3)
Taenia solium 15 (1.1)
Wuchereria bancrofti 14 (1.0)
Onchocerca volvulus 13 (1.0)
Clonorchis sinensis 8 (0.6)
Fasciola hepatica 8 (0.6)
Opisthorchis viverrini 6 (0.4)
Search performed on PubMed on March 15, 2012, using the advanced search builder. In a first step, the term
‘‘PLoS Neglected Tropical Diseases’’ was entered in the field ‘‘journal’’, which revealed 1,335 hits. In subsequent
steps, helminth-specific terms were added using the Boolean operator ‘‘AND’’. Bold text in the table indicates
parasites, parasitic infections, and diseases covered by the Disease Reference Group on Helminth Infections
(DRG4).
doi:10.1371/journal.pntd.0001646.t003
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present helminthiasis agenda [2–6]. Re-
search and capacity building must accom-
pany the entire process and innovation is
key to developing and validating the next
generation of tools and strategies [8].
For example, there is a need for
developing rapid and inexpensive integrat-
ed mapping approaches for those helmin-
thiases where the extent of the problem is
not yet appreciated [47]. The recent
development of high-resolution, spatially
explicit global databases for helminthiases
and other neglected tropical diseases
provides an exciting new opportunity
for targeting control interventions, and
subsequent monitoring, evaluation, and
surveillance [48,49]. Importantly, once the
emphasis shifts from morbidity control
towards transmission control and finally
local elimination, the need for highly
accurate diagnostics tools must be stressed.
Indeed, the diagnostics must be adapted to
the current stage of a control programme
[50]. Moreover, lessons learned from past
successful helminthiases control and elim-
ination programmes emphasise the need
for integrated approaches with close
collaboration between different sectors
(e.g., health, education, and water) and
long-term political commitment [51–53].
These issues must be seen in rapidly
changing demographic, health systems,
and social-ecological contexts [7]. A deep
understanding at different spatial and
temporal scales is mandatory so that some
of the most ancient afflictions of human-
kind can be consigned to history in the not
too distant future.
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